|
PPP1R2P3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.336370E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.809900E-02 |
| Normal-vs-Stage2 |
7.152400E-01 |
| Normal-vs-Stage3 |
6.478000E-01 |
| Normal-vs-Stage4 |
2.135200E-01 |
| Stage1-vs-Stage2 |
5.069200E-01 |
| Stage1-vs-Stage3 |
2.846000E-01 |
| Stage1-vs-Stage4 |
8.676000E-01 |
| Stage2-vs-Stage3 |
9.622000E-01 |
| Stage2-vs-Stage4 |
5.030600E-01 |
| Stage3-vs-Stage4 |
3.633200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.225000E-01 |
| Normal-vs-AfricanAmerican |
5.731800E-02 |
| Normal-vs-Asian |
3.046800E-01 |
| Caucasian-vs-AfricanAmerican |
1.949600E-01 |
| Caucasian-vs-Asian |
8.802600E-01 |
| AfricanAmerican-vs-Asian |
3.313400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.173200E-01 |
| Normal-vs-Female |
5.730100E-02 |
| Male-vs-Female |
9.499700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.376300E-02 |
| Normal-vs-Age(41-60Yrs) |
4.848200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.007600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.856800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.597390E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.283800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.837400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.887600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.949200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.206600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.992600E-01 |
| Classical-VS-Follicular |
1.782580E-01 |
| Classical-VS-Other |
2.044600E-01 |
| Classical-VS-Normal |
3.607800E-02 |
| Tall-VS-Follicular |
6.016400E-01 |
| Tall-VS-Other |
2.407600E-01 |
| Tall-VS-Normal |
3.440200E-01 |
| Follicular-VS-Other |
4.768400E-01 |
| Follicular-VS-Normal |
7.279200E-01 |
| Other-VS-Normal |
5.227000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.140600E-01 |
| Normal-vs-N1 |
8.368000E-01 |
| N0-vs-N1 |
5.285000E-01 |
|
|
